Friday News Briefs
Phase Forward In India
With news about Ranbaxy, Cedara, PHT, ChemDiv and etrials
By appearances, the services offered by 1,000-employee Omnicare CR are identical to those performed by any large or mid-sized contract research organization (CRO). Omnicare handles the same standard therapeutic areas, the same typical functional areas of work such as trial setup, project management, monitoring and SAS programming. Appearances, of course, are not always representative of the energetic thrust of a company. James Pusey, chairman and CEO of Omnicare CR, had previously helped turn around a division of MDS Pharma prior to its sale to Inc Research. Last week Pusey helped to finalize the sale of Omnicare CR to investors at Nautic Partners for an undisclosed sum. He'll continue on as the chief of Omnicare CR, which will eventually be renamed to avoid confusion with its former corporate parent, a nursing home chain. Pusey notes that several big CROs were in the bidding for Omnicare, and that Nautic was chosen partly for…more...
So far, the contract research organization (CRO) industry has been in an enviable place. The fortunes of most CROs have been healthy despite the ailing dynamics of the economy and the…more...
Sponsors are not only dissatisfied with the efficiency of their outsourcing relationships, but are also increasingly dissatisfied with their outcomes. The percentage of sponsors that is satisfied with the performance of…more...
In the early 1990s, site management organizations (SMOs) began to form. The idea was simple. Sponsors would be happier if they could go to a single company that served as the…more...
Brazil is one of only two Latin American countries (besides Argentina) to have its own contract research organization (CRO) association, and one of only a handful of countries on Earth to do so. That alone speaks volumes about the maturity and size of its clinical research market. Launched in 2006, the Brazilian association is called Associação Brasileira…more...
Things aren’t going so great for Wayne, Pa.-based contract research organization (CRO) Encorium Group (Nasdaq: ENCO). In April, its CFO/executive vice president/secretary/general counsel for the last four years got hired away by Southborough, Mass.-based CRO Averion InternationalPenn…more...
As contract research organizations (CRO) struggle to launch not just more trials but more complex studies, tension is built-in. A sponsor may ask that the CRO use a particular electronic data capture (EDC) supplier. But the sheer profusion of EDC vendors obligates some CROs to learn more than one system. Therein lies the rub. It’s as if…more...
Last week, the U.S. Supreme Court declined to hear an appeal of another court’s rejection of the suit brought by The Abigail Alliance for Better Access to Developmental Drugs. We hope that legal defeat allows Abigail to rest. With any luck, the Supreme Court has slowed a quixotic and ill-informed quest that began in 2003 with a…more...
With news about Ranbaxy, Cedara, PHT, ChemDiv and etrials
News about ICON, ethica, SAFE and CRIX.
News from Pharsight, TrialStat, NNIT, EmPower, Reagan-Udall Center.
Bulletins for October 3, 2007
Bulletins for September 28, 2007
Quintiles financial arm backed 16 companies last year. Overall, since inception to date, the Quintiles arm says it has shepherded more than $1.6 billion to small biotech firms.
The company is a member of Microsoft’s BioIT Alliance and, as of August, was collaborating with Applied Biosystems.
Organizations
Conferences
Info & Opinion
© 2012 ClinPage. All Rights Reserved.